Effects of nintedanib in patients with progressive fibrosing ILDs and differing baseline FVC: further analyses of the INBUILD trial - Université de Rennes Accéder directement au contenu
Article Dans Une Revue European Respiratory Journal Année : 2020

Effects of nintedanib in patients with progressive fibrosing ILDs and differing baseline FVC: further analyses of the INBUILD trial

Mots clés

Fichier non déposé

Dates et versions

hal-03162087 , version 1 (08-03-2021)

Identifiants

Citer

Claudia Valenzuela, Toby M. Maher, Francesco Bonella, Alberto Pesci, Stéphane Jouneau, et al.. Effects of nintedanib in patients with progressive fibrosing ILDs and differing baseline FVC: further analyses of the INBUILD trial. European Respiratory Journal, 2020, 56, ⟨10.1183/13993003.congress-2020.4577⟩. ⟨hal-03162087⟩
19 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More